one — World Parkinson Congress Blog

Posts tagged one

The FDA and Oversight of Stem Cells: Implications for Parkinson’s Disease

The FDA and Oversight of Stem Cells: Implications for Parkinson’s Disease

by Jeffrey H. Kordower, PhD and Patrik Brundin MD, PhD

Clinical ScienceJeffrey H. Kordower PhDSeptember 25, 2017Stem Cells, Clinical Trials, FDA, September 2017, one, FirstComment

Advice For Those With A Curiosity To Find A Cure For The Shaking Palsy

Advice For Those With A Curiosity To Find A Cure For The Shaking Palsy

by A.J. Lees MD, FRCP, FMedSci

Clinical Science, Basic ScienceA.J. Lees MD, FRCP, FMedSciSeptember 19, 2017Mentor, Research, September 2017, one, FirstComment

Serendipity, Benevolence, Acorns And Oaks: Enabling Improved Care Of PwP In Sub-Saharan Africa

Serendipity, Benevolence, Acorns And Oaks: Enabling Improved Care Of PwP In Sub-Saharan Africa

by Njideka U. Okubadejo, MBChB, FMCP

AdvocacyNjideka U. Okubadejo MBChB, FMCPSeptember 18, 2017Developing Countries, Manpower Development, Parkinson's Disease, September 2017, one, FirstComment

Advocacy at Altitude

Advocacy at Altitude

by Andy McDowell

Advocacy, Living with Parkinson'sAndy McDowellSeptember 11, 2017Machu Picchu, Awareness, September 2017, one, First Comment

Personal Intimacy and Sexuality in Parkinson's Disease

Personal Intimacy and Sexuality in Parkinson's Disease

by Gila Bronner, MPH, MSW

Comprehensive LivingGila Bronner MPH, MSWSeptember 4, 2017Intimacy, Sexuality, Communication, September 2017, one, First Comment

Waiting and Hoping

Waiting and Hoping

by Jon Palfreman, PhD

AdvocacyJon Palfreman PhDJuly 31, 2017Disease Modification, Alpha-Synuclein, one, FirstComment

Developing disease-modifying therapies in Parkinson’s Disease: The buzz about LRRK2 kinase inhibitors

Developing disease-modifying therapies in Parkinson’s Disease: The buzz about LRRK2 kinase inhibitors

by Andrew B. West, PhD

Photo Credit: Grove Ayers

Basic ScienceAndrew B. West, PhDJuly 10, 2017LRRK2, Michael J Fox, PPMI, Genetics, July 2017, one, FirstComment

Dance for PD

Dance for PD

by David Leventhal

Comprehensive Living, Living with Parkinson'sDavid LeventhalJuly 3, 2017Dance, Excercise, China, David Leventhal, Dance for PD, Mark Morris Dance Group, Arts in health, International, July 2017, one, First Comment

Bringing down the barriers: The Latin American Research consortium on the Genetics of Parkinson’s Disease (LARGE-PD)

by Ignacio F. Mata, PhD

Basic ScienceIgnacio F. Mata PhDJune 26, 2017Español, Spanish, Genetics, personalised medicine, LARGE-PD, genetic profile, Parkinson's Disease, parkinson, June 2017, one, FirstComment

Tom Isaacs - ROCK STAR

Tom Isaacs - ROCK STAR

by Jon Stamford, BSc PhD DSc

Living with Parkinson'sJonathan A. Stamford BSc, PhD, DScJune 19, 2017Cure for Parkinson's Trust, Community, Advocacy, June 2017, One, one, FirstComment

Towards an Understanding of the Cognitive Changes in Parkinson's

Towards an Understanding of the Cognitive Changes in Parkinson's

by Javier Castro-Hernández, MD & David Finkelstein, PhD

Basic ScienceJavier Castro-Hernandez MDJune 16, 2017cognition, parkinson, ventral tegmental area, VTA, June 2017, one, FirstComment

Personalised Medicine and Parkinson's Disease: From Genes to Personality

Personalised Medicine and Parkinson's Disease: From Genes to Personality

by Nataliya Titova, MD, PhD & K. Ray Chaudhuri, MD, FRCP, DSc

Photo credit: Grove Ayers

Clinical ScienceNataliya Titova MD, PhDJune 2, 2017non-motor, personalised medicine, June 2017, one, FirstComment

Our Favorite Memories of Tom Isaacs

Our Favorite Memories of Tom Isaacs

by the WPC Staff

Living with Parkinson'sEli PollardJune 1, 2017Cure for Parkinson's Trust, Advocacy, Music, June 2017, one, FirstComment

The Flu and You: How Viruses Influence the Risk of Parkinson's

The Flu and You: How Viruses Influence the Risk of Parkinson's

by Richard Smeyne, PhD

Basic ScienceRichard Smeyne PhDMay 29, 2017virus, influenze virus, May 2017, One, one, FirstComment

“Tip-of-the-Iceberg” Opportunities in Parkinson’s Disease

“Tip-of-the-Iceberg” Opportunities in Parkinson’s Disease

by Madelyn C. Houser & Malú G. Tansey, PhD

(Photo of Madelyn Houser in the lab.)

Basic ScienceMadelyn C. Houser PhD CandidateMay 15, 2017neuroinflammation, neuroprotection, gut, gut microbiome, non-motor, May 2017, One, one, FirstComment

The US Parkinson’s Community: A Personal Assessment of the Impact of Two Decades of Change

The US Parkinson’s Community: A Personal Assessment of the Impact of Two Decades of Change

by Robin Anthony Elliott

AdvocacyRobin Anthony ElliottMay 8, 2017World Parkinson Congress, Robin Elliott, History, Awareness, PDF, Parkinson's Disease Foundation, May 2017, One, one, FirstComment

Breakthrough on the Horizon

Breakthrough on the Horizon

by Ted Dawson, MD, PhD

Basic ScienceTed Dawson MD, PhDMay 1, 2017c-Abl inhibitors, neuroprotection, disease modification, May 2017, one, FirstComment

Sweeter may be Bitter for Parkinson's Disease

Sweeter may be Bitter for Parkinson's Disease

by Tiago Fleming Outiero, PhD

Basic ScienceTiago Fleming Outiero, PhDApril 24, 2017Alpha-Synuclein, Enviromental risk factors, Therapies, Parkinson's, April 2017, one, FirstComment